Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection

Virology Journal

Volumn 6, Issue , 2009, Pages

  Sillanpää, Maarit ^a   Melén, Krister ^a   Porkka, Päivi ^a   Fagerlund, Riku ^a   Nevalainen, Kaisu ^a   Lappalainen, Maija ^b   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HYBRID PROTEIN; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; VIRUS RNA; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; NS3 PROTEIN, HEPATITIS C VIRUS; NS4B PROTEIN, FLAVIVIRUS; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; INSECT CELL; NONHUMAN; VIRUS CORE; WESTERN BLOTTING; BLOOD; IMMUNOLOGY;

HEPATITIS C VIRUS; HEXAPODA;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 67749091073     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-84     Document Type: Article

References (29)

1. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. JL Walewski TR Keller DD Stump AD Branch, RNA 2001 7 710 721 11350035 10.1017/S1355838201010111 (Pubitemid 32405868)
2. Unravelling hepatitis C virus replication from genome to function. BD Lindenbach CM Rice, Nature 2005 436 933 938 10.1038/nature04077 16107832 (Pubitemid 41191668)
3. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. Z Xu J Choi TS Yen W Lu A Strohecker S Govindarajan D Chien MJ Selby J Ou, EMBO J 2001 20 3840 3848 11447125 10.1093/emboj/20.14.3840 (Pubitemid 32691795)
4. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. SD Griffin LP Beales DS Clarke O Worsfold SD Evans J Jaeger MP Harris DJ Rowlands, FEBS Lett 2003 535 34 38 10.1016/S0014-5793(02)03851-6 12560074 (Pubitemid 36126351)
5. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. CT Jones CL Murray DK Eastman J Tassello CM Rice, J Virol 2007 81 8374 8383 17537845 10.1128/JVI.00690-07 (Pubitemid 47242811)
6. Replication of hepatitis C virus. D Moradpour F Penin CM Rice, Nat Rev Microbiol 2007 5 453 463 10.1038/nrmicro1645 17487147 (Pubitemid 46780082)
7. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. R Gosert D Egger V Lohmann R Bartenschlager HE Blum K Bienz D Moradpour, J Virol 2003 77 5487 5492 12692249 10.1128/JVI.77.9.5487-5492.2003 (Pubitemid 36460961)
8. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. TL Tellinghuisen KL Foss J Treadaway, PLoS Pathog 2008 4 e1000032 18369478 10.1371/journal.ppat.1000032 (Pubitemid 351631090)
9. Replication of hepatitis C virus. R Bartenschlager V Lohmann, J Gen Virol 2000 81 1631 1648 10859368
10. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. V Lohmann A Roos F Korner JO Koch R Bartenschlager, J Viral Hepat 2000 7 167 174 10.1046/j.1365-2893.2000.00218.x 10849258 (Pubitemid 30337612)
11. The origin and evolution of hepatitis viruses in humans. P Simmonds, J Gen Virol 2001 82 693 712 11257174
12. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. P Simmonds J Bukh C Combet G Deleage N Enomoto S Feinstone P Halfon G Inchauspe C Kuiken G Maertens, Hepatology 2005 42 962 973 10.1002/hep.20819 16149085 (Pubitemid 41401136)
13. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. MH Nguyen EB Keeffe, Clin Gastroenterol Hepatol 2005 3 S97 S101 10.1016/S1542-3565(05)00711-1 16234071 (Pubitemid 41427738)
14. The epidemiology of hepatitis C infection in the United States. VK Rustgi, J Gastroenterol 2007 42 513 521 10.1007/s00535-007-2064-6 17653645 (Pubitemid 47190067)
15. The changing epidemiology of hepatitis C virus infection in Europe. JI Esteban S Sauleda J Quer, J Hepatol 2008 48 148 162 10.1016/j.jhep.2007.07.033 18022726 (Pubitemid 350191999)
16. Improving outcome in patients with hepatitis C virus genotype 4. SM Kamal, Am J Gastroenterol 2007 102 2582 2588 10.1111/j.1572-0241.2007.01538.x 17900328 (Pubitemid 47631799)
17. A manual of methods for baculovirus vectors and insect cell culture procedures. MD Summers GE Smith, Texas Agricultural Experiment Station Bulletin 1986 1 57
18. Expression and identification of hepatitis C virus polyprotein cleavage products. A Grakoui C Wychowski C Lin SM Feinstone CM Rice, J Virol 1993 67 1385 1395 7679746
19. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. K Melen L Kinnunen I Julkunen, J Biol Chem 2001 276 16447 16455 10.1074/jbc.M008821200 11150296
20. Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. K Melen R Fagerlund M Nyqvist P Keskinen I Julkunen, J Med Virol 2004 73 536 547 10.1002/jmv.20123 15221897 (Pubitemid 38857203)
21. Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response. F Ebeling M Lappalainen M Vuoristo H Nuutinen R Leino AL Karvonen J Lehtola R Julkunen P Pohjanpelto M Farkkila, Am J Gastroenterol 2001 96 1237 1242 10.1111/j.1572-0241.2001.03631.x 11316176
22. Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland. F Ebeling M Lappalainen M Vuoristo H Nuutinen R Leino AL Karvonen J Lehtola R Julkunen P Pohjanpelto H Tolo M Farkkila, Scand J Gastroenterol 2000 35 540 545 10.1080/003655200750023822 10868459
23. E Harlow D Lane, Antibodies: a laboratory manual Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory 1988
24. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. P Kaukinen M Sillanpaa S Kotenko R Lin J Hiscott K Melen I Julkunen, Virol J 2006 3 66 16945160 10.1186/1743-422X-3-66 (Pubitemid 44401680)
25. Virus-specific antibody titres in different phases of hepatitis C virus infection. LI Nikolaeva NP Blokhina NN Tsurikova NV Voronkova MI Miminoshvili DM Braginsky ON Yastrebova OB Booynitskaya OV Isaeva MI Michailov AI Archakov, J Viral Hepat 2002 9 429 437 10.1046/j.1365-2893.2002.00369.x 12431205 (Pubitemid 35373764)
26. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. M Beld M Penning M van Putten V Lukashov A van den Hoek M McMorrow J Goudsmit, Hepatology 1999 29 1288 1298 10.1002/hep.510290442 10094977
27. Limited humoral immunity in hepatitis C virus infection. M Chen M Sallberg A Sonnerborg O Weiland L Mattsson L Jin A Birkett D Peterson DR Milich, Gastroenterology 1999 116 135 143 10.1016/S0016-5085(99)70237-4 9869611 (Pubitemid 29013502)
28. Humoral immune response in acute hepatitis C virus infection. DM Netski T Mosbruger E Depla G Maertens SC Ray RG Hamilton S Roundtree DL Thomas J McKeating A Cox, Clin Infect Dis 2005 41 667 675 10.1086/432478 16080089 (Pubitemid 41170355)
29. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies. AS Muerhoff R Gutierrez C Kyrk T Leary G Schlauder G Dawson SM Desai, J Med Virol 2008 80 411 418 10.1002/jmv.21082 18205228 (Pubitemid 351206889)